Christopher Senner Insider Profile
11 Followers
Christopher Senner, EVP & CFO at Exelixis, holds 955.04K shares in Exelixis (Ticker: EXEL), holds ― shares in Quince Therapeutics (Ticker: QNCX). Most recently, Christopher Senner Sold ― shares of Exelixis on May 19, 2026 for an estimated value of $3.83M.
Profitable Transactions
3 out of 8 Profitable Transactions
Average Return
-6.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Christopher Senner holds in companies
Most Profitable Insider Trade
The most profitable trade made by Christopher Senner
Christopher Senner's Trading History
Exelixis
May 19, 2026
EVP & CFO
Informative Sell
3.83M
$46.48M
Quince Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Christopher Senner's performance on stock
You May Also Like
Christopher Senner insider profile FAQ
What is the percentage of profitable transactions made by Christopher Senner?
The percentage of profitable transactions made by Christopher Senner is 38%.
What is the average return per transaction made by Christopher Senner?
The average return per transaction made by Christopher Senner is -6.50%.
What stocks does Christopher Senner hold?
Christopher Senner holds: EXEL, QNCX stocks.
What was Christopher Senner’s latest transaction?
Christopher Senner latest transaction was an Informative Sell of $3.83M.
What was Christopher Senner's most profitable transaction?
Christopher Senner’s most profitable transaction was an Informative Sell of EXEL stock on September 14, 2017. The return on the trade was 37.70%.
What is Christopher Senner's role in Exelixis?
Christopher Senner's role in Exelixis is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.